Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | STAT3 | P40763 | 7/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29426039 | 0.88 | AKR1B1 (0.41) | AKR1B1MAPTMEN1KMT2AKDM4E | |
| SCHEMBL2636258 | 0.84 | MAPT (0.61) | MAPTMEN1KMT2APOLBCTDSP1 | |
| SCHEMBL29426109 | 0.82 | MAPT (0.35) | AKR1B1MAPTMEN1KMT2AKDM4E | |
| Negundoside SCHEMBL381311 | 0.81 | HSP90AA1 (0.48) | MAPTPOLBCTDSP1EPHX2STAT3 | |
| SCHEMBL29425982 | 0.76 | POLB (0.62) | MAPTMEN1KMT2APOLBCTDSP1 | |
| SCHEMBL9056451 | 0.76 | POLB (0.62) | MAPTMEN1KMT2APOLBCTDSP1 | |
| SCHEMBL29426121 | 0.73 | AKR1B1 (0.40) | AKR1B1MAPTMEN1KMT2AKDM4E | |
| SCHEMBL31179880 | 0.71 | POLB (0.64) | MAPTMEN1KMT2APOLBCTDSP1 | |
| SCHEMBL29425841 | 0.71 | POLB (0.46) | MAPTMEN1KMT2APOLBCTDSP1 | |
| SCHEMBL9058007 | 0.70 | POLB (0.46) | MAPTMEN1KMT2APOLBCTDSP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3409766-B1 | AN ESTERASE THAT IS CAPABLE OF CONVERTING IRIDOIDS AND SECO-IRIDOIDS | N ZYME BIOTEC GMBH (DE) | 2022-03-09 | — | — | EP | disclosed |